Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.38 Analyst target: $27.00 Upside: 323.20%
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.
See the full interactive analysis & chart →Informational only — not investment advice.